This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Fundamental Analysis Of Zydus Lifesciences: Following the pandemic outbreak, global health issues have gained attention, resulting in a greater focus on pharmaceutical corporations. Zydus Lifesciences is one of these Indian pharmaceutical businesses. During the pandemic, the stock attained its all-time high but soon declined.
Some notable pharmaceutical companies have made their way to the Nifty Index and we’re going to perform a fundamental analysis of Divis Laboratories. Overview: Indian Pharmaceutical Industry When you consume medicine for certain ailments and diseases, you’re recommended by your doctor to consume it for its curing effect.
Fundamental Analysis Of Aarti Industries : Specialty chemicals have become essential in various industries ranging from pharmaceuticals, electronics, agriculture, and automotive. Earlier, the company run its speciality chemicals and pharmaceutical business under one name. This gives the company a 5-year CAGR of 11.54% on its revenue.
Revenue Breakup Data Source: Annual Report The company’s financial report reported a 19% increase in revenue from operations from Rs.9920Cr The net profit after tax increased by 7% from Rs.1207 The net profit after tax increased by 14% from Rs.1889 The net profit after tax increased by 14% from Rs.455
Fundamental Analysis Of Neuland Laboratories: Following the pandemic outbreak, worldwide health issues have become more prominent, leading to an increased focus on pharmaceutical companies. Industry Overview India is the 12th-largest market in terms of value and the world’s third-largest pharmaceutical producer in terms of volume.
Additionally, it also develops prebiotics and formulations among other products for the pharmaceutical industry. Basic chemistry products and specialty products contributed to 81% and 19% of the total revenue of TCL during the financial year 2022-23 respectively. to reach $ 6,780 by 2025.
FY 2022-23 Annual Report Its chemicals find their end applications in a multitude of industries including petrochemicals, rubber, agrochemicals, paper, pharmaceuticals, detergents, and more. Recently, the company started a home lifestyle centre called Creaticity to tap the value-added real estate market in India.
As a feather in its cap, with a capacity of over 2,32,00 TPA, Laxmi Organic is one of the largest producers of Ethyl Acetate in India commanding a 33% market share. Furthermore, it also has domestic leadership in Diketene derivatives with a 55% market share.
Profit After Tax stood at Rs 19476.72 It has over 50 years of experience in the manufacturing of specialty chemicals such as Specialty Paste PVC resin and Custom Manufactured Chemicals for the agrochemical, pharmaceutical, and fine chemicals sectors. Overall for FY 2022-23, Revenue from operations stood at Rs 76518.21 from Rs 65204.96
Product Offerings The company’s products have several uses in mining, pharmaceuticals, shipbuilding, power, oil, chemicals, textiles, printing, paper, transportation, electronics, telecommunications, military, medical, railways, food & drinks, and plastics. Year Total income (Rs in Cr) Profit after tax (Rs in Cr) 2023 3,107.9
CPL’s products are used in various industries including agrochemicals, automotive, food & beverages, cables & wires, chemicals & lubricants, pharmaceuticals, packaging, dairy, and more. Control Print is debt-free micro cap stock with a market valuation of Rs 1,053 crore. 932 EPS 195 Stock P/E 8 RoCE 20.6%
They cause an increase in per capita income, tax collections and the GDP as well. FDI is better than FII which is volatile in nature and moves to the stock market. They influence the market and cause an increase in demand for local currency and direct inflation. FIIs enhance the flow of capital in the country.
The trailing twelve months (TTM) profit after tax of IGL after the December 2022 quarter results stood at Rs 1,673 crore on sales of Rs 12,865 crore. CMP ₹460 Market Cap (Cr.) The trailing twelve months (TTM) profit after tax was recorded at Rs 420 crore on an income of Rs 5,064 crore. 31,600 EPS ₹23 Stock P/E 20 RoCE 30.9%
Vivek Sharma is a PGDM Finance graduate and has over 16 years of experience in Indian financialmarkets, primarily in equity research. Top Mutual Funds For SIP #2 – IDFC Tax Advantage (ELSS) Direct Plan-Growth Fund Company IDFC Asset Management Company Ltd Size (AUM in Cr) 4,033 3-yr returns (CAGR) 22.56 1-yr return 2.5
In FY23, their revenue from healthcare services was 96.03%, drugs and pharmaceutical supplies were 2.34%, and other operating revenue (ancillary activities, service exports, sponsorship, and educational income) was 1.63%. The increase in net profits is due to a reduction in interest costs as well as a deferred tax effect.
Kelly Nilsson, CFP®, CDFA®, JD Kelly’s journey in finance began in 1992, and for the first 17 years of her career she worked for financialmarketing firms and insurance companies, during which time her clients were financial advisors. He is a father to three children and a husband to an ER physician.
Company Overview Sun Pharmaceutical Industries Ltd. Over the last 40 years, it has become the largest pharma company in India and the fourth-largest speciality generic pharmaceutical company in the world with a market capitalisation of Rs 2,25,000 crore. Now we’ll race through financials of the the stock.
India is emerging as a major player in the pharmaceutical industry, particularly in the development of cancer drugs. The rising number of cancer cases, both domestic and international, creates immense opportunities for pharmaceutical companies specializing in oncology treatments. Current Market Price ₹ 1,866.7
So that’s fundamentally different, and it makes it harder for us to become a profession that it is, I think for those self-governing bodies… Wright: Well, I guess the only caveat to medicine is when you get into pharmaceuticals. I hope you’ll at least join my newsletter about financial advisor lead generation.
What’s more, pharmaceutical companies have created very effective therapeutics, including Paxlovid, a game-changing antiviral pill manufactured by Pfizer. History tells us this will never happen, but the mere game of political brinksmanship could rattle markets in the short-run. All these risks and fears are nothing new.
We organize all of the trending information in your field so you don't have to. Join 36,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content